A recent study demonstrated that patients and a mouse model with a homozygous mutation in TFRC showed combined immunodeficiency characterized by decreased proliferation of T and B cells and defective class switching (Jabara et al., 2016). The gene discussed is TFRC; the disease is immunodeficiency disease.